Plasma thymus and activation‐regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plasma thymus and activation‐regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphoma

Published:2020-07 Issue:1 Volume:1 Page:152-160
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Zijtregtop Eline A. M.¹²^ORCID,Meyer‐Wentrup Friederike²,Wong Wai‐Chu¹,Hoogendijk Raoull²,Lopez‐Yurda Marta²³,Zwaan Christian M.¹²,Beishuizen Auke¹²

Affiliation:

1. Department of Pediatric Hematology and OncologyErasmus Medical Centre ‐ Sophia Children's Hospital Rotterdam The Netherlands

2. Department of Hemato‐oncologyPrincess Máxima Centre for Pediatric Oncology Utrecht The Netherlands

3. Department of BiometricsNetherlands Cancer Institute Amsterdam The Netherlands

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.41

Reference26 articles.

1. Hodgkin lymphoma

2. The role of cytokines in classical Hodgkin lymphoma

3. The Role of Chemokines in Hodgkin's Disease

4. Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment

5. Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL17, CCL22 and their receptor CCR4 in hematologic malignancies;Discover Oncology;2024-09-06

2. Nivolumab plus Brentuximab vedotin +/- bendamustine combination therapy: a safe and effective treatment in pediatric recurrent and refractory classical Hodgkin lymphoma;Frontiers in Immunology;2023-07-31

3. Machine Learning Logistic Regression Model for Early Decision Making in Referral of Children with Cervical Lymphadenopathy Suspected of Lymphoma;Cancers;2023-02-12

4. Thymus and activation‐regulated chemokine ( TARC ) as treatment response marker for paediatric Hodgkin lymphoma: A pilot study;British Journal of Haematology;2022-09-20

5. Is thymus and activation-regulated chemokine a forgotten diagnostic and minimal residual disease marker in classical Hodgkin lymphoma?;memo - Magazine of European Medical Oncology;2021-10-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3